Experts at ASN Kidney Week say earlier detection, national CKD screening, and faster uptake are needed to bring new therapies to patients.
Rachael Morton, PhD
Advertisement
Rachael Morton, PhD, is a professor and director of health economics and health technology assessment at the NHMRC Clinical Trials Centre and faculty of medicine at the University of Sydney.
Articles by Rachael Morton, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Four Major Idiopathic Pulmonary Fibrosis Advances From 2026
2
5 Things to Know About HHS's Interim Peptide Compounding Policy
3
Elagolix Noninferior to Dienogest for Endometriosis Pain in Phase 3 Trial
4
Kidney Week 2026 Recap: IgAN Advances, Value-Based Care, CKD Care Gaps
5